AXIM Biotechnologies CEO to Speak at National Symposium on Medical Cannabis in Mexico City

AXIM® Biotechnologies (OTC:AXIM) announced that its Chief Executive Officer, George E. Anastassov, MD, DDS, MBA, will speak at the First National Symposium on Medical Cannabis, dedicated to providing the medical community of Mexico with information about the medical value of cannabidiol (CBD) derivatives in Mexico City on Oct. 8.
As quoted in the press release:

Dr. Anastassov will speak to health professionals in attendance about the value of cannabinoids and hemp derivatives, including how AXIM Biotech is using cannabinoids (both synthetic and natural) in the Company’s extensive line of pharmaceutical and nutraceutical products.